Your browser doesn't support javascript.
loading
New prospects for PCSK9 inhibition?
Landmesser, Ulf; Chapman, M John; Stock, Jane K; Amarenco, Pierre; Belch, Jill J F; Borén, Jan; Farnier, Michel; Ference, Brian A; Gielen, Stephan; Graham, Ian; Grobbee, Diederick E; Hovingh, G Kees; Lüscher, Thomas F; Piepoli, Massimo F; Ray, Kausik K; Stroes, Erik S; Wiklund, Olov; Windecker, Stephan; Zamorano, Jose Luis; Pinto, Fausto; Tokgözoglu, Lale; Bax, Jeroen J; Catapano, Alberico L.
Afiliação
  • Landmesser U; Department of Cardiology, Charité - Universitätsmedizin Berlin (CBF), and Institute of Health (BIH), Berlin, Germany.
  • Chapman MJ; National Institute for Health and Medical Research (INSERM), University of Pierre and Marie Curie, Pitié-Salpêtrière Hospital, Paris, France.
  • Stock JK; European Atherosclerosis Society, Gothenburg, Sweden.
  • Amarenco P; Department of Neurology and Stroke Centre, Bichat Hospital, Paris-Diderot-Sorbonne University, Paris, France.
  • Belch JJF; Institute of Cardiovascular Research, Ninewells Hospital and Medical School, Dundee, UK.
  • Borén J; Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital, and Wallenberg Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Farnier M; Lipid Clinic, Point Medical, and Department of Cardiology, CHU Dijon-Bourgogne, Dijon, France.
  • Ference BA; Division of Cardiovascular Medicine, Division of Translational Research and Clinical Epidemiology, Wayne State University School of Medicine, Detroit, MI, USA.
  • Gielen S; Martin-Luther-University Halle/Wittenberg, University Hospital, Department of Internal Medicine III, Halle/Saale, Germany.
  • Graham I; Trinity College Dublin, Ireland.
  • Grobbee DE; Julius Global Health, the Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Hovingh GK; Academic Medical Center, Department of Vascular Medicine, University of Amsterdam, Amsterdam, The Netherlands.
  • Lüscher TF; University Heart Center, Department of Cardiology, University Hospital Zurich, and Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.
  • Piepoli MF; G Da Saliceto Hospital, Heart Failure Unit, Cardiac Department, Piacenza, Italy.
  • Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College, London, UK.
  • Stroes ES; Academic Medical Center, Department of Vascular Medicine, University of Amsterdam, Amsterdam, The Netherlands.
  • Wiklund O; Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Windecker S; Department of Cardiology, Swiss Cardiovascular Center, University Hospital, Bern, Switzerland.
  • Zamorano JL; Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.
  • Pinto F; Cardiology Department, CCUL, CAML, Faculdade de Medicina, Universidade de Lisboa, Portugal.
  • Tokgözoglu L; Department of Cardiology, Hacettepe University, Ankara, Turkey.
  • Bax JJ; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Catapano AL; University of Milan and Multimedica IRCSS Milano, Italy.
Eur Heart J ; 39(27): 2600-2601, 2018 07 14.
Article em En | MEDLINE | ID: mdl-29579192
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hiperlipoproteinemia Tipo II Limite: Humans Idioma: En Revista: Eur Heart J Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hiperlipoproteinemia Tipo II Limite: Humans Idioma: En Revista: Eur Heart J Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha